vs
LINDBLAD EXPEDITIONS HOLDINGS, INC.（LIND）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是LINDBLAD EXPEDITIONS HOLDINGS, INC.的1.2倍（$219.9M vs $183.2M），Orthofix Medical Inc.净利率更高（-1.0% vs -12.9%，领先11.8%），LINDBLAD EXPEDITIONS HOLDINGS, INC.同比增速更快（23.3% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $3.5M），过去两年LINDBLAD EXPEDITIONS HOLDINGS, INC.的营收复合增速更高（9.2% vs 8.0%）
林德布拉德探险控股是一家专业探险旅行企业，总部位于美国纽约。目前公司运营15艘探险邮轮，载客量从28人到150人不等，可为旅行者提供覆盖全球七大洲目的地的探险邮轮旅程。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
LIND vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.2倍
$183.2M
营收增速更快
LIND
高出21.3%
2.0%
净利率更高
OFIX
高出11.8%
-12.9%
自由现金流更多
OFIX
多$13.3M
$3.5M
两年增速更快
LIND
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $183.2M | $219.9M |
| 净利润 | $-23.6M | $-2.2M |
| 毛利率 | 40.3% | 71.1% |
| 营业利润率 | -3.0% | 0.2% |
| 净利率 | -12.9% | -1.0% |
| 营收同比 | 23.3% | 2.0% |
| 净利润同比 | 6.0% | 92.4% |
| 每股收益（稀释后） | $-0.45 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LINDOFIX
| Q4 25 | $183.2M | $219.9M | ||
| Q3 25 | $240.2M | $205.6M | ||
| Q2 25 | $167.9M | $203.1M | ||
| Q1 25 | $179.7M | $193.6M | ||
| Q4 24 | $148.6M | $215.7M | ||
| Q3 24 | $206.0M | $196.6M | ||
| Q2 24 | $136.5M | $198.6M | ||
| Q1 24 | $153.6M | $188.6M |
净利润LINDOFIX
| Q4 25 | $-23.6M | $-2.2M | ||
| Q3 25 | $1.2M | $-22.8M | ||
| Q2 25 | $-8.5M | $-14.1M | ||
| Q1 25 | $1.2M | $-53.1M | ||
| Q4 24 | $-25.0M | $-29.1M | ||
| Q3 24 | $22.5M | $-27.4M | ||
| Q2 24 | $-24.7M | $-33.4M | ||
| Q1 24 | $-4.0M | $-36.0M |
毛利率LINDOFIX
| Q4 25 | 40.3% | 71.1% | ||
| Q3 25 | 48.2% | 72.2% | ||
| Q2 25 | 45.6% | 68.7% | ||
| Q1 25 | 48.3% | 62.8% | ||
| Q4 24 | 42.5% | 69.0% | ||
| Q3 24 | 46.7% | 68.7% | ||
| Q2 24 | 39.2% | 67.8% | ||
| Q1 24 | 45.0% | 67.5% |
营业利润率LINDOFIX
| Q4 25 | -3.0% | 0.2% | ||
| Q3 25 | 15.0% | -8.3% | ||
| Q2 25 | 2.6% | -7.9% | ||
| Q1 25 | 5.9% | -25.2% | ||
| Q4 24 | -5.1% | -5.3% | ||
| Q3 24 | 14.3% | -9.6% | ||
| Q2 24 | -6.0% | -12.5% | ||
| Q1 24 | 5.1% | -15.6% |
净利率LINDOFIX
| Q4 25 | -12.9% | -1.0% | ||
| Q3 25 | 0.5% | -11.1% | ||
| Q2 25 | -5.1% | -6.9% | ||
| Q1 25 | 0.6% | -27.4% | ||
| Q4 24 | -16.9% | -13.5% | ||
| Q3 24 | 10.9% | -13.9% | ||
| Q2 24 | -18.1% | -16.8% | ||
| Q1 24 | -2.6% | -19.1% |
每股收益（稀释后）LINDOFIX
| Q4 25 | $-0.45 | $-0.05 | ||
| Q3 25 | $0.00 | $-0.57 | ||
| Q2 25 | $-0.18 | $-0.36 | ||
| Q1 25 | $0.00 | $-1.35 | ||
| Q4 24 | $-0.45 | $-0.76 | ||
| Q3 24 | $0.36 | $-0.71 | ||
| Q2 24 | $-0.48 | $-0.88 | ||
| Q1 24 | $-0.10 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $256.7M | $82.0M |
| 总债务越低越好 | $662.7M | — |
| 股东权益账面价值 | $-284.5M | $450.0M |
| 总资产 | $980.0M | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LINDOFIX
| Q4 25 | $256.7M | $82.0M | ||
| Q3 25 | $261.8M | $62.9M | ||
| Q2 25 | $200.9M | $65.6M | ||
| Q1 25 | $188.9M | $58.0M | ||
| Q4 24 | $183.9M | $83.2M | ||
| Q3 24 | $193.9M | $30.1M | ||
| Q2 24 | $168.1M | $26.4M | ||
| Q1 24 | $177.7M | $27.0M |
总债务LINDOFIX
| Q4 25 | $662.7M | — | ||
| Q3 25 | $663.5M | $157.2M | ||
| Q2 25 | $627.3M | $157.0M | ||
| Q1 25 | $626.4M | $156.9M | ||
| Q4 24 | $625.5M | $157.0M | ||
| Q3 24 | $624.5M | $118.5M | ||
| Q2 24 | $623.6M | $118.0M | ||
| Q1 24 | $622.7M | $118.2M |
股东权益LINDOFIX
| Q4 25 | $-284.5M | $450.0M | ||
| Q3 25 | $-256.6M | $442.5M | ||
| Q2 25 | $-263.8M | $458.3M | ||
| Q1 25 | $-252.2M | $458.3M | ||
| Q4 24 | $-253.1M | $503.1M | ||
| Q3 24 | $-226.9M | $525.9M | ||
| Q2 24 | $-255.5M | $546.0M | ||
| Q1 24 | $-227.4M | $570.3M |
总资产LINDOFIX
| Q4 25 | $980.0M | $850.6M | ||
| Q3 25 | $976.5M | $832.6M | ||
| Q2 25 | $936.5M | $837.2M | ||
| Q1 25 | $908.8M | $823.1M | ||
| Q4 24 | $876.9M | $893.3M | ||
| Q3 24 | $889.8M | $867.9M | ||
| Q2 24 | $858.3M | $882.0M | ||
| Q1 24 | $868.0M | $906.0M |
负债/权益比LINDOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $3.5M | $16.8M |
| 自由现金流率自由现金流/营收 | 1.9% | 7.6% |
| 资本支出强度资本支出/营收 | 6.0% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $63.8M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流LINDOFIX
| Q4 25 | $14.4M | $27.7M | ||
| Q3 25 | $19.5M | $12.4M | ||
| Q2 25 | $29.2M | $11.6M | ||
| Q1 25 | $48.4M | $-18.4M | ||
| Q4 24 | $1.7M | $23.7M | ||
| Q3 24 | $28.1M | $11.7M | ||
| Q2 24 | $18.6M | $9.0M | ||
| Q1 24 | $43.9M | $-18.6M |
自由现金流LINDOFIX
| Q4 25 | $3.5M | $16.8M | ||
| Q3 25 | $11.9M | $2.5M | ||
| Q2 25 | $13.5M | $4.5M | ||
| Q1 25 | $35.0M | $-25.1M | ||
| Q4 24 | $-8.2M | $15.2M | ||
| Q3 24 | $18.4M | $6.3M | ||
| Q2 24 | $11.2M | $-360.0K | ||
| Q1 24 | $37.4M | $-29.1M |
自由现金流率LINDOFIX
| Q4 25 | 1.9% | 7.6% | ||
| Q3 25 | 5.0% | 1.2% | ||
| Q2 25 | 8.0% | 2.2% | ||
| Q1 25 | 19.5% | -13.0% | ||
| Q4 24 | -5.5% | 7.0% | ||
| Q3 24 | 8.9% | 3.2% | ||
| Q2 24 | 8.2% | -0.2% | ||
| Q1 24 | 24.4% | -15.4% |
资本支出强度LINDOFIX
| Q4 25 | 6.0% | 4.9% | ||
| Q3 25 | 3.2% | 4.8% | ||
| Q2 25 | 9.4% | 3.5% | ||
| Q1 25 | 7.5% | 3.5% | ||
| Q4 24 | 6.6% | 4.0% | ||
| Q3 24 | 4.7% | 2.7% | ||
| Q2 24 | 5.4% | 4.7% | ||
| Q1 24 | 4.2% | 5.6% |
现金转化率LINDOFIX
| Q4 25 | — | — | ||
| Q3 25 | 16.41× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 41.69× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.25× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LIND
| Guest Ticket | $96.5M | 53% |
| Landexperience | $67.3M | 37% |
| Other Tour | $19.4M | 11% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
